Pharmaceutical

Request for TOC Request for Sample
BUY NOW

Europe Excipients Market – Industry Trends and Forecast to 2028

Pharmaceutical | Published Report | Apr 2021 | Europe | 350 Pages | No of Tables: 411 | No of Figures: 61

Report Description

Europe Excipients Market, By Origin (Organic, Inorganic), Category (Primary Excipients, Secondary Excipients), Products (Polymers, Sugars, Alcohols, Minerals, Gelatin, Others), Chemistry Type (Plant, Animals, Synthetic, Minerals), Chemical Synthesis (Lactose Monohydrate, Sucralose, Polysorbate, Benzyl Alcohol, Cetosteary Aclohol, Soy Lecithin, Pregelatinized Starch, Others), Functionality (Binders and Adhesives, Disintegrants, Coating Material, Disintegrants, Solubilizers, Flavors, Sweetening Agents, Diluents, Lubricants, Buffers, Emulsifying Agents, Preservatives, Antioxidants, Sorbents, Solvents, Emollients, Glidients, Chelating Agents, Antifoaming Agents, Others), Dosage Form (Solid, Semi-Solid, Liquid), Route of Administration (Oral Excipients, Topical Excipients, Parenteral Excipients, Other Excipients), End User (Pharmaceutical and Biopharmaceutical Companies, Contract Formulators, Research Organization and Academics, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Turkey, Lithuania, Rest of Europe) Industry Trends and Forecast to 2028

Get Exclusive Sample Copy of this Report Here

Market Analysis and Insights: Europe Excipients Market

The excipients market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.8% in the forecast period of 2021 to 2028 and is expected to reach USD 2,379.08 million by 2028. Increasing demand for alternative routes of delivery/dosage forms and increasing need for pharmaceutical excipients across varied therapeutic areas are the major drivers which propelled the demand of the excipients market in the forecast period.

Pharmaceutical excipients involve everything in a drug except that of the active pharmaceutical ingredients. These molecules don’t possess any medicinal property and are ultimately used for enhancing the physiological absorption of the drug. Excipients are inert in nature and it allows the drug molecule to apply to patients in the right form.

The technological advancements in multifunctional excipients act as a driver for the excipients market growth in the forecast period. The long duration of the drug development process is expected to hinder the excipients market in the forecast period. The strategic initiatives by market players act as an opportunity for the growth of the excipients market. The safety consideration in storage & transportation acts as a challenge for the growth of the excipients market.

The excipients market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the excipients market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Get Exclusive Sample Copy of this Report Here

Excipients Market Scope and Market Size

The excipients market is categorized into ten notable segments which are based on the origin, category, products, chemistry type, chemical synthesis, functionality, dosage forms, route of administration, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of origin, the excipients market is segmented into organic and inorganic. In 2021, organic origin holds the highest market share due to non-toxic characteristic of organic chemicals used as excipients.
  • On the basis of category, the excipients market is segmented into primary excipients and secondary excipients. In 2021, primary excipients segment is dominating the market as the segment includes fillers, adhesives, lubricants and other crucial excipients.  
  • On the basis of products, the excipients market is segmented into polymers, sugars, alcohols, minerals, gelatin and others. In 2021, polymers segment is dominating the market because polymers are used as gelatin shells in the manufacturing of capsules.
  • On the basis of chemistry type, the excipients market is segmented into plant, animals, synthetic and minerals. In 2021, plant segment is dominating the market due to less expensive, non-toxic nature, biodegradable in nature and do not show any adverse effects of side effect on the human beings.
  • On the basis of chemical synthesis, the excipients market is segmented into lactose monohydrate, sucralose, polysorbate, benzyl alcohol, cetosteary aclohol, soy lecithin, pregelatinized starch and others. In 2021, lactose monohydrate segment is dominating the market due to its multiple properties.
  • On the basis of functionality, the excipients market is segmented into binders and adhesives, disintegrants, coating material, disintegrants, solubilizers, flavors, sweetening agents, diluents, lubricants, buffers, emulsifying agents, preservatives, antioxidants, sorbents, solvents, emollients, glidients, chelating agents, antifoaming agents and others. In 2021, binders and adhesives segment is dominating the market due to its properties.
  • On the basis of dosage forms, the excipients market is segmented into solid, semi-solid and liquid. In 2021, solid segment is dominating the market as most of the excipients are used in manufacturing of solid dosage form.
  • On the basis of route of administration, the excipients market is segmented into oral excipients, topical excipients, parenteral excipients and other excipients. In 2021, oral excipients segment dominates in the market as majority of drugs including the first line therapy are available in the oral form with the highest effectiveness having strong onset of action.
  • On the basis of end user, the excipients market is segmented into pharmaceutical and biopharmaceutical companies, contract formulators, research organization and academics and others. In 2021, pharmaceutical and biopharmaceutical companies segment dominates in the market as most of the excipients are used in pharmaceutical and biopharmaceutical companies because these companies are responsible for the production of medicines in all dosage forms such as solid, semi-solid and liquid.
  • On the basis of distribution channel, the excipients market is segmented into direct tender, retail sales and others. In 2021, direct tender segment is dominating in the market as it is the primary source of distribution of excipients.

Europe Excipients Market Country Level Analysis

Europe excipients market is analysed and market size information is provided based on the country, origin, category, products, chemistry type, chemical synthesis, functionality, dosage forms, route of administration, end user and distribution channel as referenced above.

The countries covered in the Europe excipients market report are the Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Turkey, Lithuania and rest of Europe.

Germany is dominating in the Europe excipients market with the substantial CAGR in the forecast period due to innovations in biopharmaceuticals, rising focus on orphan drugs and technological advancements in multifunctional excipients.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.  

Strategic Initiatives by Market Players Is creating new opportunities in the Excipients Market 

The excipients market also provides you with detailed market analysis for every country growth in excipients, impact of advancement in excipients and changes in regulatory scenarios with their support for the excipients market. The data is available for historic period 2011 to 2019.  

Competitive Landscape and Excipients Market Share Analysis

The excipients market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Europe excipients market.

The major companies covered in the Europe excipients market report are DOW, Roquette Frères, JRS Pharma, Evonik Industries AG, The Lubrizol Corporation (a subsidiary of Berkshire Hathaway Inc.), BASF SE, Ashland, Kerry Group PLC, Shin-Etsu Chemical Co., Ltd., Colorcon, Chemische Fabrik Budenheim, Peter Greven GmbH & Co. KG, ADM, Croda International Plc, BENEO, Avantor, Inc., Omya AG, DFE Pharma, Pfanstiehl, Inc., MEGGLE Group Wasserburg among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the excipients market.

For instance,  

  • In September 2020, Roquette Frères has entered into a partnership with Barentz for pharmaceuticals distribution in the U.S. Both these companies are working in European markets creating distribution channel. This partnership will increase product portfolio of the company.

Partnership, new product development and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for excipients through expanded range of size.   

 


SKU-

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE EXCIPIENTS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 ORIGIN LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHT

4.1 EUROPE EXCIPIENTS MARKET: COUNTRIES WITH DATA OF IMPORTS AND EXPORTS

4.2 EUROPE EXCIPIETNS MARKET: COLOMBIA DATA OF THE ORIGIN COUNTRY OF THE IMPORTS

4.3 EUROPE EXCIPIENTS MARKET: COLOMBIA DATA OF THE IMPORTS AND EXPORTS BY MOLECULES IN VALUES AND VOLUMES

5 EUROPE EXCIPIENTS MARKET: REGULATORY SCENARIO

5.1 THE CANADA REGULATORY GUIDANCE FOR NON CLINICAL SAFETY EVALUATION OF PHARMACEUTICAL EXCIPIENTS

5.2 JAPAN REGULATORY FRAMEWORK FOR EXCIPIENTS

5.3 MIDDLE EAST AND AFRICA REGULATORY FRAMEWORK FOR EXCIPIENTS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 TECHNOLOGICAL ADVANCEMENTS IN MULTIFUNCTIONAL EXCIPIENTS

6.1.2 INCREASING NEED FOR PHARMACEUTICAL PRODUCTS ACROSS VARIED THERAPEUTIC AREAS

6.1.3 INNOVATIONS IN BIOPHARMACEUTICALS

6.1.4 INCREASING DEMAND & AVAILABILITY OF GENERIC DRUGS

6.1.5 RISING FOCUS ON ORPHAN DRUGS

6.2 RESTRAINTS

6.2.1 STRINGENT REGULATIONS

6.2.2 LONG DURATION OF DRUG DEVELOPMENT PROCESS

6.2.3 HIGH COST OF EXPERIMENTAL STUDIES OF EXCIPIENTS

6.3 OPPORTUNITIES

6.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS

6.3.2 RISING DEMAND FOR EASE OF USE

6.3.3 RISING DISPOSABLE INCOME

6.3.4 INCREASING DEMAND FOR ALTERNATIVE ROUTES OF DELIVERY/DOSAGE FORMS

6.3.5 ASSOCIATED SIDE EFFECTS

6.3.6 SAFETY CONSIDERATION IN STORAGE & TRANSPORTATION

6.3.7 LACK OF NOVEL PHARMACEUTICAL EXCIPIENTS

7 IMPACT OF COVID-19 ON EUROPE EXCIPIENTS MARKET

7.1 IMPACT ON PRICE

7.2 IMPACT ON DEMAND

7.3 MPACT ON SUPPLY CHAIN

7.4 STRATEGIC DECISION BY MANUFACTURERS

7.5 KEY INITIATIVES BY MARKET PLAYERS DURING COVID-19

7.6 CONCLUSION

8 EUROPE EXCIPIENTS MARKET, BY ORIGIN

8.1 OVERVIEW

8.2 ORGANIC

8.3 INORGANIC

9 EUROPE EXCIPIENTS MARKET, BY CATEGORY

9.1 OVERVIEW

9.2 PRIMARY EXCIPIENTS

9.3 SECONDARY EXCIPIENTS

10 EUROPE EXCIPIENTS MARKET, BY PRODUCTS

10.1 OVERVIEW

10.2 POLYMERS

10.2.1 MCC

10.2.2 HPMC

10.2.3 ETHYL CELLULOSE

10.2.4 METHYL CELLULOSE

10.2.5 CMC

10.2.6 CROSCARMELLOSE SODIUM

10.2.7 POVIDONE

10.2.8 PREGELATINIZED STARCH

10.2.9 SODIUM STARCH GLYCOL

10.2.10 POLYETHYLENE GLYCOL

10.2.11 ACRYLIC POLYMERS

10.3 SUGAR

10.3.1 LACTOSE

10.3.2 SUCROSE

10.3.3 OTHERS

10.4 ALCOHOL

10.4.1 PROPYLENE GLYCOL

10.4.2 SORBITOL

10.4.3 MANNITOL

10.4.4 GLYCERIN

10.4.5 OTHERS

10.5 MINERALS

10.5.1 CALCIUM PHOSPHATE

10.5.2 CALCIUM CARBONATE

10.5.3 CLAY

10.5.4 SILICON DIOXIDE

10.5.5 TITANIUM DIOXIDE

10.5.6 OTHERS

10.6 GELATIN

10.7 OTHERS

11 EUROPE EXCIPIENTS MARKET, BY CHEMISTRY TYPE

11.1 OVERVIEW

11.2 PLANT

11.3 ANIMALS

11.4 SYNTHETIC

11.5 MINERALS

12 EUROPE EXCIPIENTS MARKET, BY CHEMISTRY SYNTHESIS

12.1 OVERVIEW

12.2 LACTOSE MONOHYDRATE

12.3 SUCRALOSE

12.4 POLYSORBATE

12.5 BENZYL ALCOHOL

12.6 CETOSTEARY ACLOHOL

12.7 SOY LECITHIN

12.8 PREGELATINIZED STARCH

12.9 OTHERS

13 EUROPE EXCIPIENTS MARKET, BY FUNCTIONALITY

13.1 OVERVIEW

13.2 BINDERS AND ADHESIVES

13.3 DISINTEGRANTS

13.4 COATING MATERIAL

13.5 COLORING AGENTS

13.6 SOLUBILIZERS

13.7 FLAVORS

13.8 SWEETENING AGENTS

13.9 DILUENTS

13.1 LUBRICANTS

13.11 BUFFERS

13.12 EMULSIFYING AGENTS

13.13 PRESERVATIVES

13.14 ANTIOXIDANTS

13.15 SORBENTS

13.16 SOLVENTS

13.17 EMOLLIENTS

13.18 GLIDIENTS

13.19 CHELATING AGENTS

13.2 ANTIFOAMING AGENTS

13.21 OTHERS

14 EUROPE EXCIPIENTS MARKET, BY DOSAGE FORM

14.1 OVERVIEW

14.2 SOLID

14.2.1 PLANT

14.2.2 ANIMALS

14.2.3 SYNTHETIC

14.2.4 MINERALS

14.3 SEMI-SOLID

14.3.1 PLANT

14.3.2 ANIMALS

14.3.3 SYNTHETIC

14.3.4 MINERALS

14.4 LIQUID

14.4.1 PLANT

14.4.2 ANIMALS

14.4.3 SYNTHETIC

14.4.4 MINERALS

15 EUROPE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION

15.1 OVERVIEW

15.2 ORAL EXCIPIENTS

15.3 TOPICAL EXCIPIENTS

15.4 PARENTERAL EXCIPIENTS

15.5 OTHER EXCIPIENTS

16 EUROPE EXCIPIENTS MARKET, BY END USER

16.1 OVERVIEW

16.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES

16.3 CONTRACT FORMULATORS

16.4 RESEARCH ORGANIZATION AND ACADEMICS

16.5 OTHERS

17 EUROPE EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL

17.1 OVERVIEW

17.2 DIRECT TENDER

17.3 RETAIL SALES

17.4 OTHERS

18 EUROPE EXCIPIENTS MARKET, BY GEOGRAPHY

18.1 EUROPE

18.1.1 GERMANY

18.1.2 FRANCE

18.1.3 ITALY

18.1.4 SPAIN

18.1.5 U.K.

18.1.6 SWITZERLAND

18.1.7 IRELAND

18.1.8 NETHERLANDS

18.1.9 RUSSIA

18.1.10 HUNGARY

18.1.11 TURKEY

18.1.12 AUSTRIA

18.1.13 POLAND

18.1.14 NORWAY

18.1.15 LITHUANIA

18.1.16 REST OF EUROPE

19 EUROPE EXCIPIENTS MARKET: COMPANY LANDSCAPE

19.1 COMPANY SHARE ANALYSIS: EUROPE

20 SWOT ANALYSIS

21 COMPANY PROFILES

21.1 DOW

21.1.1 COMPANY SNAPSHOT

21.1.2 REVENUE ANALYSIS

21.1.3 COMPANY SHARE ANALYSIS

21.1.4 PRODUCT PORTFOLIO

21.1.5 RECENT DEVELOPMENTS

21.2 ROQUETTE FRÈRES

21.2.1 COMPANY SNAPSHOT

21.2.2 COMPANY SHARE ANALYSIS

21.2.3 PRODUCT PORTFOLIO

21.2.4 RECENT DEVELOPMENTS

21.3 JRS PHARMA

21.3.1 COMPANY SNAPSHOT

21.3.2 COMPANY SHARE ANALYSIS

21.3.3 PRODUCT PORTFOLIO

21.3.4 RECENT DEVELOPMENTS

21.4 EVONIK INDUSTRIES AG

21.4.1 COMPANY SNAPSHOT

21.4.2 REVENUE ANALYSIS

21.4.3 COMPANY SHARE ANALYSIS

21.4.4 PRODUCT PORTFOLIO

21.4.5 RECENT DEVELOPMENTS

21.5 THE LUBRIZOL CORPORATION (A SUBSIDIARY OF BERKSHIRE HATHAWAY INC.)

21.5.1 COMPANY SNAPSHOT

21.5.2 REVENUE ANALYSIS

21.5.3 COMPANY SHARE ANALYSIS

21.5.4 PRODUCT PORTFOLIO

21.5.5 RECENT DEVELOPMENT

21.6 BASF SE

21.6.1 COMPANY SNAPSHOT

21.6.2 REVENUE ANALYSIS

21.6.3 PRODUCT PORTFOLIO

21.6.4 RECENT DEVELOPMENTS

21.7 ASHLAND

21.7.1 COMPANY SNAPSHOT

21.7.2 REVENUE ANALYSIS

21.7.3 PRODUCT PORTFOLIO

21.7.4 RECENT DEVELOPMENTS

21.8 KERRY GROUP PLC

21.8.1 COMPANY SNAPSHOT

21.8.2 REVENUE ANALYSIS

21.8.3 PRODUCT PORTFOLIO

21.8.4 RECENT DEVELOPMENTS

21.9 SHIN-ETSU CHEMICAL CO., LTD.

21.9.1 COMPANY SNAPSHOT

21.9.2 REVENUE ANALYSIS

21.9.3 PRODUCT PORTFOLIO

21.9.4 RECENT DEVELOPMENTS

21.1 COLORCON

21.10.1 COMPANY SNAPSHOT

21.10.2 PRODUCT PORTFOLIO

21.10.3 RECENT DEVELOPMENTS

21.11 ADM

21.11.1 COMPANY SNAPSHOT

21.11.2 REVENUE ANALYSIS

21.11.3 PRODUCT PORTFOLIO

21.11.4 RECENT DEVELOPMENTS

21.12 AVANTOR, INC.

21.12.1 COMPANY SNAPSHOT

21.12.2 REVENUE ANALYSIS

21.12.3 PRODUCT PORTFOLIO

21.12.4 RECENT DEVELOPMENTS

21.13 BENEO

21.13.1 COMPANY SNAPSHOT

21.13.2 PRODUCT PORTFOLIO

21.13.3 RECENT DEVELOPMENTS

21.14 CHEMISCHE FABRIK BUDENHEIM

21.14.1 COMPANY SNAPSHOT

21.14.2 PRODUCT PORTFOLIO

21.14.3 RECENT DEVELOPMENTS

21.15 CRODA INTERNATIONAL PLC

21.15.1 COMPANY SNAPSHOT

21.15.2 REVENUE ANALYSIS

21.15.3 PRODUCT PORTFOLIO

21.15.4 RECENT DEVELOPMENTS

21.16 DFE PHARMA

21.16.1 COMPANY SNAPSHOT

21.16.2 PRODUCT PORTFOLIO

21.16.3 RECENT DEVELOPMENTS

21.17 MEGGLE GROUP WASSERBURG

21.17.1 COMPANY SNAPSHOT

21.17.2 PRODUCT PORTFOLIO

21.17.3 RECENT DEVELOPMENTS

21.18 OMYA AG

21.18.1 COMPANY SNAPSHOT

21.18.2 PRODUCT PORTFOLIO

21.18.3 RECENT DEVELOPMENTS

21.19 PETER GREVEN GMBH & CO. KG

21.19.1 COMPANY SNAPSHOT

21.19.2 PRODUCT PORTFOLIO

21.19.3 RECENT DEVELOPMENTS

21.2 PFANSTIEHL, INC.

21.20.1 COMPANY SNAPSHOT

21.20.2 PRODUCT PORTFOLIO

21.20.3 RECENT DEVELOPMENTS

22 QUESTIONNAIRE

23 RELATED REPORTS

List of Table

TABLE 1 EUROPE EXCIPIENTS MARKET, BY ORIGIN, 2017-2028 (USD MILLION)

TABLE 2 EUROPE ORGANIC IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 3 EUROPE INORGANIC IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 4 EUROPE EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)

TABLE 5 EUROPE PRIMARY EXCIPIENTS IN EXCIPIENT MARKETS, BY REGION, 2017-2028 (USD MILLION)

TABLE 6 EUROPE SECONDARY EXCIPIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 7 EUROPE EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 8 EUROPE POLYMERS EXCIPIENTS IN EXCIPIENT MARKETS, BY REGION, 2017-2028 (USD MILLION)

TABLE 9 EUROPE POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)

TABLE 10 EUROPE SUGARS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 11 EUROPE SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 12 EUROPE ALCOHOLS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 13 EUROPE ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 14 EUROPE MINERALS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 15 EUROPE MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 16 EUROPE GELATIN IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 17 EUROPE OTHERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 18 EUROPE EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)

TABLE 19 EUROPE PLANT IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 20 EUROPE ANIMALS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 21 EUROPE SYNTHETIC IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 22 EUROPE MINERALS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 23 EUROPE EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)

TABLE 24 EUROPE LACTOSE MONOHYDRATE IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 25 EUROPE SUCRALOSE IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 26 EUROPE POLYSORBATE IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 27 EUROPE BENZYL ALCOHOL IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 28 EUROPE CETOSTEARY ACLOHOL IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 29 EUROPE SOY LECITHIN IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 30 EUROPE PREGELATINIZED STARCH IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 31 EUROPE OTHERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 32 EUROPE EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)

TABLE 33 EUROPE BINDERS AND ADHESIVES IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 34 EUROPE DISINTEGRANTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 35 EUROPE COATING MATERIAL IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 36 EUROPE COLORING AGENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 37 EUROPE SOLUBILIZERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 38 EUROPE FLAVORS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 39 EUROPE SWEETENING AGENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 40 EUROPE DILUENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 41 EUROPE LUBRICANTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 42 EUROPE BUFFERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 43 EUROPE EMULSIFYING AGENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 44 EUROPE PRESERVATIVES IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 45 EUROPE ANTIOXIDANTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 46 EUROPE SORBENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 47 EUROPE SOLVENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 48 EUROPE EMOLLIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 49 EUROPE GLIDIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 50 EUROPE CHELATING AGENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 51 EUROPE ANTIFOAMING AGENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 52 EUROPE OTHERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 53 EUROPE EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 54 EUROPE SOLID IN EXCIPIENT MARKETS, BY REGION, 2017-2028 (USD MILLION)

TABLE 55 EUROPE SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 56 EUROPE SEMI- SOLID IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 57 EUROPE SEMI- SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 58 EUROPE LIQUID IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 59 EUROPE LIQUID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 60 EUROPE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)

TABLE 61 EUROPE ORAL EXCIPIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 62 EUROPE TOPICAL EXCIPIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 63 EUROPE PARENTERAL EXCIPIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 64 EUROPE OTHER EXCIPIENTS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 65 EUROPE EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)

TABLE 66 EUROPE PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 67 EUROPE CONTRACT FORMULATORS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 68 EUROPE RESEARCH ORGANIZATION AND ACADEMICS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 69 EUROPE OTHERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 70 EUROPE EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL, 2017-2028 (USD MILLION)

TABLE 71 EUROPE DIRECT TENDER IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 72 EUROPE RETAIL SALES IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 73 EUROPE OTHERS IN EXCIPIENTS MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 74 EUROPE EXCIPIENTS MARKET, BY COUNTRY, 2017-2028 (USD MILLION)

TABLE 75 EUROPE EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)

TABLE 76 EUROPE EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)

TABLE 77 EUROPE EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 78 EUROPE EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)

TABLE 79 EUROPE EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)

TABLE 80 EUROPE POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)

TABLE 81 EUROPE SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 82 EUROPE ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 83 EUROPE MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 84 EUROPE EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)

TABLE 85 EUROPE EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)

TABLE 86 EUROPE EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)

TABLE 87 EUROPE EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)

TABLE 88 EUROPE EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)

TABLE 89 EUROPE EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 90 EUROPE SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 91 EUROPE SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 92 EUROPE LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 93 EUROPE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)

TABLE 94 EUROPE EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)

TABLE 95 EUROPE EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)

TABLE 96 GERMANY EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)

TABLE 97 GERMANY EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)

TABLE 98 GERMANY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 99 GERMANY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)

TABLE 100 GERMANY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)

TABLE 101 GERMANY POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)

TABLE 102 GERMANY SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 103 GERMANY ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 104 GERMANY MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 105 GERMANY EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)

TABLE 106 GERMANY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)

TABLE 107 GERMANY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)

TABLE 108 GERMANY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)

TABLE 109 GERMANY EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)

TABLE 110 GERMANY EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 111 GERMANY SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 112 GERMANY SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 113 EUROPE LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 114 EUROPE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)

TABLE 115 GERMANY EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)

TABLE 116 GERMANY EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)

TABLE 117 FRANCE EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)

TABLE 118 FRANCE EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)

TABLE 119 FRANCE EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 120 FRANCE EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)

TABLE 121 FRANCE EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)

TABLE 122 FRANCE POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)

TABLE 123 FRANCE SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 124 FRANCE ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 125 FRANCE MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 126 FRANCE EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)

TABLE 127 FRANCE EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)

TABLE 128 FRANCE EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)

TABLE 129 FRANCE EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)

TABLE 130 FRANCE EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)

TABLE 131 FRANCE EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 132 FRANCE SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 133 FRANCE SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 134 FRANCE LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 135 FRANCE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)

TABLE 136 FRANCE EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)

TABLE 137 FRANCE EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)

TABLE 138 ITALY EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)

TABLE 139 ITALY EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)

TABLE 140 ITALY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 141 ITALY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)

TABLE 142 ITALY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)

TABLE 143 ITALY POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)

TABLE 144 ITALY SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 145 ITALY ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 146 ITALY MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 147 ITALY EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)

TABLE 148 ITALY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)

TABLE 149 ITALY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)

TABLE 150 ITALY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)

TABLE 151 ITALY EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)

TABLE 152 ITALY EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 153 ITALY SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 154 ITALY SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 155 ITALY LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 156 EUROPE EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)

TABLE 157 ITALY EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)

TABLE 158 ITALY EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)

TABLE 159 SPAIN EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)

TABLE 160 SPAIN EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)

TABLE 161 SPAIN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 162 SPAIN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)

TABLE 163 SPAIN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)

TABLE 164 SPAIN POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)

TABLE 165 SPAIN SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 166 SPAIN ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 167 SPAIN MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 168 SPAIN EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)

TABLE 169 SPAIN EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)

TABLE 170 SPAIN EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)

TABLE 171 SPAIN EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)

TABLE 172 SPAIN EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)

TABLE 173 SPAIN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 174 SPAIN SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 175 SPAIN SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 176 SPAIN LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 177 SPAIN EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)

TABLE 178 SPAIN EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)

TABLE 179 SPAIN EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)

TABLE 180 U.K. EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)

TABLE 181 U.K. EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)

TABLE 182 U.K. EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 183 U.K. EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)

TABLE 184 U.K. EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)

TABLE 185 U.K. POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)

TABLE 186 U.K. SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 187 U.K. ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 188 U.K. MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 189 U.K. EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)

TABLE 190 U.K. EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)

TABLE 191 U.K. EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)

TABLE 192 U.K. EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)

TABLE 193 U.K. EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)

TABLE 194 U.K. EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 195 U.K. SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 196 U.K. SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 197 U.K. LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 198 U.K. EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)

TABLE 199 U.K. EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)

TABLE 200 U.K. EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)

TABLE 201 SWITZERLAND EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)

TABLE 202 SWITZERLAND EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)

TABLE 203 SWITZERLAND EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 204 SWITZERLAND EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)

TABLE 205 SWITZERLAND EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)

TABLE 206 SWITZERLAND POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)

TABLE 207 SWITZERLAND SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 208 SWITZERLAND ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 209 SWITZERLAND MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 210 SWITZERLAND EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)

TABLE 211 SWITZERLAND EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)

TABLE 212 SWITZERLAND EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)

TABLE 213 SWITZERLAND EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)

TABLE 214 SWITZERLAND EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)

TABLE 215 SWITZERLAND EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 216 SWITZERLAND SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 217 SWITZERLAND SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 218 SWITZERLAND LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 219 SWITZERLAND EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)

TABLE 220 SWITZERLAND EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)

TABLE 221 SWITZERLAND EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)

TABLE 222 IRELAND EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)

TABLE 223 IRELAND EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)

TABLE 224 IRELAND EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 225 IRELAND EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)

TABLE 226 IRELAND EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)

TABLE 227 IRELAND POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)

TABLE 228 IRELAND SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 229 IRELAND ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 230 IRELAND MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 231 IRELAND EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)

TABLE 232 IRELAND EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)

TABLE 233 IRELAND EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)

TABLE 234 IRELAND EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)

TABLE 235 IRELAND EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)

TABLE 236 IRELAND EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 237 IRELAND SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 238 IRELAND SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 239 IRELAND LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 240 IRELAND EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)

TABLE 241 IRELAND EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)

TABLE 242 IRELAND EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)

TABLE 243 NETHERLANDS EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)

TABLE 244 NETHERLANDS EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)

TABLE 245 NETHERLANDS EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 246 NETHERLANDS EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)

TABLE 247 NETHERLANDS EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)

TABLE 248 NETHERLANDS POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)

TABLE 249 NETHERLANDS SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 250 NETHERLANDS ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 251 NETHERLANDS MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 252 NETHERLANDS EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)

TABLE 253 NETHERLANDS EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)

TABLE 254 NETHERLANDS EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)

TABLE 255 NETHERLANDS EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)

TABLE 256 NETHERLANDS EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)

TABLE 257 NETHERLANDS EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 258 NETHERLANDS SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 259 NETHERLANDS SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 260 NETHERLANDS LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 261 NETHERLANDS EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)

TABLE 262 NETHERLANDS EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)

TABLE 263 NETHERLANDS EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)

TABLE 264 RUSSIA EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)

TABLE 265 RUSSIA EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)

TABLE 266 RUSSIA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 267 RUSSIA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)

TABLE 268 RUSSIA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)

TABLE 269 RUSSIA POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)

TABLE 270 RUSSIA SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 271 RUSSIA ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 272 RUSSIA MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 273 RUSSIA EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)

TABLE 274 RUSSIA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)

TABLE 275 RUSSIA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)

TABLE 276 RUSSIA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)

TABLE 277 RUSSIA EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)

TABLE 278 RUSSIA EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 279 RUSSIA SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 280 RUSSIA SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 281 RUSSIA LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 282 RUSSIA EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)

TABLE 283 RUSSIA EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)

TABLE 284 RUSSIA EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)

TABLE 285 HUNGARY EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)

TABLE 286 HUNGARY EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)

TABLE 287 HUNGARY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 288 HUNGARY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)

TABLE 289 HUNGARY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)

TABLE 290 HUNGARY POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)

TABLE 291 HUNGARY SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 292 HUNGARY ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 293 HUNGARY MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 294 HUNGARY EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)

TABLE 295 HUNGARY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)

TABLE 296 HUNGARY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)

TABLE 297 HUNGARY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)

TABLE 298 HUNGARY EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)

TABLE 299 HUNGARY EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 300 HUNGARY SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 301 HUNGARY SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 302 HUNGARY LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 303 HUNGARY EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)

TABLE 304 HUNGARY EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)

TABLE 305 HUNGARY EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)

TABLE 306 TURKEY EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)

TABLE 307 TURKEY EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)

TABLE 308 TURKEY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 309 TURKEY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)

TABLE 310 TURKEY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)

TABLE 311 TURKEY POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)

TABLE 312 TURKEY SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 313 TURKEY ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 314 TURKEY MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 315 TURKEY EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)

TABLE 316 TURKEY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)

TABLE 317 TURKEY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)

TABLE 318 TURKEY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)

TABLE 319 TURKEY EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)

TABLE 320 TURKEY EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 321 TURKEY SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 322 TURKEY SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 323 TURKEY LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 324 TURKEY EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)

TABLE 325 TURKEY EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)

TABLE 326 TURKEY EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)

TABLE 327 AUSTRIA EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)

TABLE 328 AUSTRIA EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)

TABLE 329 AUSTRIA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 330 AUSTRIA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)

TABLE 331 AUSTRIA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)

TABLE 332 AUSTRIA POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)

TABLE 333 AUSTRIA SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 334 AUSTRIA ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 335 AUSTRIA MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 336 AUSTRIA EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)

TABLE 337 AUSTRIA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)

TABLE 338 AUSTRIA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)

TABLE 339 AUSTRIA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)

TABLE 340 AUSTRIA EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)

TABLE 341 AUSTRIA EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 342 AUSTRIA SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 343 AUSTRIA SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 344 AUSTRIA LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 345 AUSTRIA EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)

TABLE 346 AUSTRIA EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)

TABLE 347 AUSTRIA EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)

TABLE 348 POLAND EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)

TABLE 349 POLAND EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)

TABLE 350 POLAND EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 351 POLAND EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)

TABLE 352 POLAND EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)

TABLE 353 POLAND POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)

TABLE 354 POLAND SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 355 POLAND ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 356 POLAND MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 357 POLAND EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)

TABLE 358 POLAND EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)

TABLE 359 POLAND EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)

TABLE 360 POLAND EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)

TABLE 361 POLAND EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)

TABLE 362 POLAND EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 363 POLAND SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 364 POLAND SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 365 POLAND LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 366 POLAND EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)

TABLE 367 POLAND EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)

TABLE 368 POLAND EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)

TABLE 369 NORWAY EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)

TABLE 370 NORWAY EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)

TABLE 371 NORWAY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 372 NORWAY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)

TABLE 373 NORWAY EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)

TABLE 374 NORWAY POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)

TABLE 375 NORWAY SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 376 NORWAY ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 377 NORWAY MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 378 NORWAY EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)

TABLE 379 NORWAY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)

TABLE 380 NORWAY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)

TABLE 381 NORWAY EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)

TABLE 382 NORWAY EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)

TABLE 383 NORWAY EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 384 NORWAY SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 385 NORWAY SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 386 NORWAY LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 387 NORWAY EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)

TABLE 388 NORWAY EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)

TABLE 389 NORWAY EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)

TABLE 390 LITHUANIA EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)

TABLE 391 LITHUANIA EXCIPIENTS MARKET, BY CATEGORY, 2017-2028 (USD MILLION)

TABLE 392 LITHUANIA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 393 LITHUANIA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (UNITS)

TABLE 394 LITHUANIA EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (ASP)

TABLE 395 LITHUANIA POLYMERS IN EXCIPIENTS MARKET, BY PRODUCTS , 2017-2028 (USD MILLION)

TABLE 396 LITHUANIA SUGAR IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 397 LITHUANIA ALCOHOL IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 398 LITHUANIA MINERALS IN EXCIPIENTS MARKET, BY PRODUCTS, 2017-2028 (USD MILLION)

TABLE 399 LITHUANIA EXCIPIENTS MARKET, BY CHEMISTRY TYPE, 2017-2028 (USD MILLION)

TABLE 400 LITHUANIA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (USD MILLION)

TABLE 401 LITHUANIA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (UNITS)

TABLE 402 LITHUANIA EXCIPIENTS MARKET, BY CHEMICAL SYNTHESIS, 2017-2028 (ASP)

TABLE 403 LITHUANIA EXCIPIENTS MARKET, BY FUNCTIONALITY, 2017-2028 (USD MILLION)

TABLE 404 LITHUANIA EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 405 LITHUANIA SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 406 LITHUANIA SEMI-SOLID IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 407 LITHUANIA LIQUIDS IN EXCIPIENTS MARKET, BY DOSAGE FORMS, 2017-2028 (USD MILLION)

TABLE 408 LITHUANIA EXCIPIENTS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2028 (USD MILLION)

TABLE 409 LITHUANIA EXCIPIENTS MARKET, BY END USER, 2017-2028 (USD MILLION)

TABLE 410 LITHUANIA EXCIPIENTS MARKET, BY DISTRIBUTION CHANNEL 2017-2028 (USD MILLION)

TABLE 411 REST OF EUROPE EXCIPIENTS MARKET, BY ORIGIN 2017-2028 (USD MILLION)

List of Figure

FIGURE 1 EUROPE EXCIPIENTS MARKET: SEGMENTATION

FIGURE 2 EUROPE EXCIPIENTS MARKET : DATA TRIANGULATION

FIGURE 3 EUROPE EXCIPIENTS MARKET: DROC ANALYSIS

FIGURE 4 EUROPE EXCIPIENTS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE EXCIPIENTS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE EXCIPIENTS MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE EXCIPIENTS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE EXCIPIENTS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE EXCIPIENTS MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 10 EUROPE EXCIPIENTS MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 EUROPE EXCIPIENTS MARKET: SEGMENTATION

FIGURE 12 TECHNOLOGICAL ADVANCEMENTS IN MULTIFUNCTIONAL EXCIPIENTS AND INNOVATION IN BIOPHARMACEUTICALS IS DRIVING THE EUROPE EXCIPIENTS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 ORGANIC SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE EXCIPIENTS MARKET IN 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE EUROPE EXCIPIENTS MARKET

FIGURE 15 APPROVAL OF GENERIC MEDICINES BY USFDA

FIGURE 16 EUROPE EXCIPIENTS MARKET: BY ORIGIN, 2020

FIGURE 17 EUROPE EXCIPIENTS MARKET: BY ORIGIN, 2020-2028 (USD MILLION)

FIGURE 18 EUROPE EXCIPIENTS MARKET: BY ORIGIN, CAGR (2020-2028)

FIGURE 19 EUROPE EXCIPIENTS MARKET: BY ORIGIN, LIFELINE CURVE

FIGURE 20 EUROPE EXCIPIENTS MARKET: BY CATEGORY, 2020

FIGURE 21 EUROPE EXCIPIENTS MARKET: BY CATEGORY, 2020-2028 (USD MILLION)

FIGURE 22 EUROPE EXCIPIENTS MARKET: BY CATEGORY, CAGR (2020-2028)

FIGURE 23 EUROPE EXCIPIENTS MARKET: BY CATEGORY, LIFELINE CURVE

FIGURE 24 EUROPE EXCIPIENTS MARKET: BY PRODUCTS, 2020

FIGURE 25 EUROPE EXCIPIENTS MARKET: BY PRODUCTS, 2020-2028 (USD MILLION)

FIGURE 26 EUROPE EXCIPIENTS MARKET: BY PRODUCTS, CAGR (2020-2028)

FIGURE 27 EUROPE EXCIPIENTS MARKET: BY PRODUCTS, LIFELINE CURVE

FIGURE 28 EUROPE EXCIPIENTS MARKET: BY CHEMISTRY TYPE, 2020

FIGURE 29 EUROPE EXCIPIENTS MARKET: BY CHEMISTRY TYPE, 2020-2028 (USD MILLION)

FIGURE 30 EUROPE EXCIPIENTS MARKET: BY CHEMISTRY TYPE, CAGR (2020-2028)

FIGURE 31 EUROPE EXCIPIENTS MARKET: BY CHEMISTRY TYPE, LIFELINE CURVE

FIGURE 32 EUROPE EXCIPIENTS MARKET: BY CHEMICAL SYNTHESIS, 2020

FIGURE 33 EUROPE EXCIPIENTS MARKET: BY CHEMICAL SYNTHESIS, 2020-2028 (USD MILLION)

FIGURE 34 EUROPE EXCIPIENTS MARKET: BY CHEMICAL SYNTHESIS, CAGR (2020-2028)

FIGURE 35 EUROPE EXCIPIENTS MARKET: BY CHEMICAL SYNTHESIS, LIFELINE CURVE

FIGURE 36 EUROPE EXCIPIENTS MARKET: BY FUNCTIONALITY, 2020

FIGURE 37 EUROPE EXCIPIENTS MARKET: BY FUNCTIONALITY, 2020-2028 (USD MILLION)

FIGURE 38 EUROPE EXCIPIENTS MARKET: BY FUNCTIONALITY, CAGR (2020-2028)

FIGURE 39 EUROPE EXCIPIENTS MARKET: BY FUNCTIONALITY, LIFELINE CURVE

FIGURE 40 EUROPE EXCIPIENTS MARKET: BY DOSAGE FORMS, 2020

FIGURE 41 EUROPE EXCIPIENTS MARKET: BY DOSAGE FORMS, 2020-2028 (USD MILLION)

FIGURE 42 EUROPE EXCIPIENTS MARKET: BY DOSAGE FORMS, CAGR (2020-2028)

FIGURE 43 EUROPE EXCIPIENTS MARKET: BY DOSAGE FORMS, LIFELINE CURVE

FIGURE 44 EUROPE EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, 2020

FIGURE 45 EUROPE EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, 2020-2028 (USD MILLION)

FIGURE 46 EUROPE EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2020-2028)

FIGURE 47 EUROPE EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 48 EUROPE EXCIPIENTS MARKET: BY END USER, 2020

FIGURE 49 EUROPE EXCIPIENTS MARKET: BY END USER, 2020-2028 (USD MILLION)

FIGURE 50 EUROPE EXCIPIENTS MARKET: BY END USER, CAGR (2020-2028)

FIGURE 51 EUROPE EXCIPIENTS MARKET: BY END USER, LIFELINE CURVE

FIGURE 52 EUROPE EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 53 EUROPE EXCIPIENTS MARKET: BY DISTRIBUTION CHAN, 2020-2028 (USD MILLION)

FIGURE 54 EUROPE EXCIPIENTS MARKET: BY DISTRIBUTION CHAN, CAGR (2020-2028)

FIGURE 55 EUROPE EXCIPIENTS MARKET: BY DISTRIBUTION CHAN, LIFELINE CURVE

FIGURE 56 EUROPE EXCIPIENTS MARKET: SNAPSHOT (2020)

FIGURE 57 EUROPE EXCIPIENTS MARKET: BY COUNTRY (2020)

FIGURE 58 EUROPE EXCIPIENTS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 59 EUROPE EXCIPIENTS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 60 EUROPE EXCIPIENTS MARKET: BY ORIGIN (2021-2028)

FIGURE 61 EUROPE EXCIPIENTS MARKET: COMPANY SHARE 2020 (%)

View Infographics

FIGURE 1 EUROPE EXCIPIENTS MARKET: SEGMENTATION

FIGURE 2 EUROPE EXCIPIENTS MARKET : DATA TRIANGULATION

FIGURE 3 EUROPE EXCIPIENTS MARKET: DROC ANALYSIS

FIGURE 4 EUROPE EXCIPIENTS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE EXCIPIENTS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE EXCIPIENTS MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE EXCIPIENTS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE EXCIPIENTS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE EXCIPIENTS MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 10 EUROPE EXCIPIENTS MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 EUROPE EXCIPIENTS MARKET: SEGMENTATION

FIGURE 12 TECHNOLOGICAL ADVANCEMENTS IN MULTIFUNCTIONAL EXCIPIENTS AND INNOVATION IN BIOPHARMACEUTICALS IS DRIVING THE EUROPE EXCIPIENTS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 ORGANIC SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE EXCIPIENTS MARKET IN 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE EUROPE EXCIPIENTS MARKET

FIGURE 15 APPROVAL OF GENERIC MEDICINES BY USFDA

FIGURE 16 EUROPE EXCIPIENTS MARKET: BY ORIGIN, 2020

FIGURE 17 EUROPE EXCIPIENTS MARKET: BY ORIGIN, 2020-2028 (USD MILLION)

FIGURE 18 EUROPE EXCIPIENTS MARKET: BY ORIGIN, CAGR (2020-2028)

FIGURE 19 EUROPE EXCIPIENTS MARKET: BY ORIGIN, LIFELINE CURVE

FIGURE 20 EUROPE EXCIPIENTS MARKET: BY CATEGORY, 2020

FIGURE 21 EUROPE EXCIPIENTS MARKET: BY CATEGORY, 2020-2028 (USD MILLION)

FIGURE 22 EUROPE EXCIPIENTS MARKET: BY CATEGORY, CAGR (2020-2028)

FIGURE 23 EUROPE EXCIPIENTS MARKET: BY CATEGORY, LIFELINE CURVE

FIGURE 24 EUROPE EXCIPIENTS MARKET: BY PRODUCTS, 2020

FIGURE 25 EUROPE EXCIPIENTS MARKET: BY PRODUCTS, 2020-2028 (USD MILLION)

FIGURE 26 EUROPE EXCIPIENTS MARKET: BY PRODUCTS, CAGR (2020-2028)

FIGURE 27 EUROPE EXCIPIENTS MARKET: BY PRODUCTS, LIFELINE CURVE

FIGURE 28 EUROPE EXCIPIENTS MARKET: BY CHEMISTRY TYPE, 2020

FIGURE 29 EUROPE EXCIPIENTS MARKET: BY CHEMISTRY TYPE, 2020-2028 (USD MILLION)

FIGURE 30 EUROPE EXCIPIENTS MARKET: BY CHEMISTRY TYPE, CAGR (2020-2028)

FIGURE 31 EUROPE EXCIPIENTS MARKET: BY CHEMISTRY TYPE, LIFELINE CURVE

FIGURE 32 EUROPE EXCIPIENTS MARKET: BY CHEMICAL SYNTHESIS, 2020

FIGURE 33 EUROPE EXCIPIENTS MARKET: BY CHEMICAL SYNTHESIS, 2020-2028 (USD MILLION)

FIGURE 34 EUROPE EXCIPIENTS MARKET: BY CHEMICAL SYNTHESIS, CAGR (2020-2028)

FIGURE 35 EUROPE EXCIPIENTS MARKET: BY CHEMICAL SYNTHESIS, LIFELINE CURVE

FIGURE 36 EUROPE EXCIPIENTS MARKET: BY FUNCTIONALITY, 2020

FIGURE 37 EUROPE EXCIPIENTS MARKET: BY FUNCTIONALITY, 2020-2028 (USD MILLION)

FIGURE 38 EUROPE EXCIPIENTS MARKET: BY FUNCTIONALITY, CAGR (2020-2028)

FIGURE 39 EUROPE EXCIPIENTS MARKET: BY FUNCTIONALITY, LIFELINE CURVE

FIGURE 40 EUROPE EXCIPIENTS MARKET: BY DOSAGE FORMS, 2020

FIGURE 41 EUROPE EXCIPIENTS MARKET: BY DOSAGE FORMS, 2020-2028 (USD MILLION)

FIGURE 42 EUROPE EXCIPIENTS MARKET: BY DOSAGE FORMS, CAGR (2020-2028)

FIGURE 43 EUROPE EXCIPIENTS MARKET: BY DOSAGE FORMS, LIFELINE CURVE

FIGURE 44 EUROPE EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, 2020

FIGURE 45 EUROPE EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, 2020-2028 (USD MILLION)

FIGURE 46 EUROPE EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2020-2028)

FIGURE 47 EUROPE EXCIPIENTS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 48 EUROPE EXCIPIENTS MARKET: BY END USER, 2020

FIGURE 49 EUROPE EXCIPIENTS MARKET: BY END USER, 2020-2028 (USD MILLION)

FIGURE 50 EUROPE EXCIPIENTS MARKET: BY END USER, CAGR (2020-2028)

FIGURE 51 EUROPE EXCIPIENTS MARKET: BY END USER, LIFELINE CURVE

FIGURE 52 EUROPE EXCIPIENTS MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 53 EUROPE EXCIPIENTS MARKET: BY DISTRIBUTION CHAN, 2020-2028 (USD MILLION)

FIGURE 54 EUROPE EXCIPIENTS MARKET: BY DISTRIBUTION CHAN, CAGR (2020-2028)

FIGURE 55 EUROPE EXCIPIENTS MARKET: BY DISTRIBUTION CHAN, LIFELINE CURVE

FIGURE 56 EUROPE EXCIPIENTS MARKET: SNAPSHOT (2020)

FIGURE 57 EUROPE EXCIPIENTS MARKET: BY COUNTRY (2020)

FIGURE 58 EUROPE EXCIPIENTS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 59 EUROPE EXCIPIENTS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 60 EUROPE EXCIPIENTS MARKET: BY ORIGIN (2021-2028)

FIGURE 61 EUROPE EXCIPIENTS MARKET: COMPANY SHARE 2020 (%)

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19